徕博科 LH 深 沪
已收盘 11-13 16:00:00 美东时间
370.48
-1.840
-0.49%
华盛通- 最 高374.17
- 今 开374.17
- 成交量 48.90万股
- 最 低 369.11
- 昨 收 372.32
- 总市值 3008.30万
- 52周最高 375.10
- 市盈率 静 35.42
- 换手率 602.18%
- 52周最低 242.84
- 委 比 -81.82%
- 总股本 8.12万
- 历史最高 375.10
- 量 比 0.77
- 振 幅 1.36%
- 历史最低 27.60
- 每 手 1
- 风险率 31.31%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多徕博科收跌0.26%，成交额1.89亿美元
11月11日，徕博科（LH）收跌0.26%，报370.88美元，成交额1.89亿美元，市值301.15亿美元。 行情数据 • 开盘价：370.04美元 • 最高...
11-11 05:41
财报速睇 | 徕博科 2026财年Q3营收38.10亿美元，同比增长6.9%；归母净利润2.63亿美元，同比增长0.7%
华盛资讯10月31日讯，徕博科公布2026财年Q3业绩，公司Q3营收38.10亿美元，同比增长6.9%，归母净利润2.63亿美元，同比增长0.7%。
10-31 06:16
美股大行评级 | 潜在涨幅1112.12%！Canaccord Genuity上调Wave Life Sciences目标价至44美元，维持"买入"评级
今日重点评级关注：Canaccord Genuity：维持Wave Life Sciences"买入"评级，目标价从42美元升至44美元；Canaccord Genuity：维持Pharming Group"买入"评级，目标价从38美元升至41美元
10-30 12:30
Baird Maintains Outperform on Labcorp Holdings, Raises Price Target to $396
Baird analyst Eric Coldwell maintains Labcorp Holdings (NYSE:LH) with a Outperform and raises the price target from $361 to $396.
10-29 19:40
Labcorp Targets Margin Growth, Absorbs Policy Headwinds
Labcorp Holdings (NYSE:LH) stock is trading at a 52-week high after the company reported upbeat third-quarter earnings and raised its fiscal outlook. Labcorp reported third-quarter adjusted earnings of $4.78, beating the consensus of $4.66. Sales reached $3.81 billion, up 6.9% year over year, beatin...
10-29 01:54
Vertiv, Evercore, Brinker, GE HealthCare And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were mixed, with the Dow Jones gaining around 100 points on Wednesday. Shares of Vertiv Holdings Co (NYSE:VRT) rose sharply after the company reported better-than-expected third-quarter financial results and raised its FY26 guidance above estimates. Vertiv reported quarterly earnings of ...
10-28 22:54
财报速睇 | 徕博科 2026财年Q3营收38.10亿美元，同比增长6.9%；归母净利润2.63亿美元，同比增长0.7%
华盛资讯10月28日讯，徕博科公布2026财年Q3业绩，公司Q3营收38.10亿美元，同比增长6.9%，归母净利润2.63亿美元，同比增长0.7%。
10-28 19:36
Labcorp Holdings Raises FY2026 Adj EPS Guidance from $18.10-$18.55 to $18.30-$18.70 vs $18.36 Est; Raises FY2026 Sales Guidance from $14.710B-$14.827B to $14.779B-$14.887B vs $14.749B Est
Labcorp Holdings (NYSE:LH) raises FY2026 Adj EPS guidance from $18.10-$18.55 to $18.30-$18.70 vs $18.36 analyst estimate. Raises FY2026 sales outlook from $14.710 billion-$14.827 billion to $14.779 billion-$14.887 billion vs $14.749 billion estimate.
10-28 18:51
Laboratory Corp Q3 Adj. EPS $4.78 Beats $4.66 Estimate, Sales $3.810B Beat $3.759B Estimate
Laboratory Corp (NYSE:LH) reported quarterly earnings of $4.78 per share which beat the analyst consensus estimate of $4.66 by 2.58 percent. This is a 14.35 percent increase over earnings of $4.18 per share from the same period last year. The company reported quarterly sales of $3.810 billion which ...
10-28 18:51
